These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


345 related items for PubMed ID: 8200011

  • 21. [Treatment of hypercholesterolemic patients of different age with simvastatin: 1-year study].
    Pernigotti L, Bo M, Poli L, Zanocchi M, Fiandra U, Pedrazzini V, Fabris F.
    Recenti Prog Med; 1991 Mar; 82(3):155-62. PubMed ID: 2047557
    [Abstract] [Full Text] [Related]

  • 22. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
    Mol MJ, Stuyt PM, Stalenhoef AF.
    Ned Tijdschr Geneeskd; 1989 Feb 18; 133(7):362-6. PubMed ID: 2927555
    [Abstract] [Full Text] [Related]

  • 23. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L, Szostak WB, Grzybowska B, Białobrzeska-Paluszkiewicz J, Wiśniewska B, Stolarska I.
    Kardiol Pol; 2004 Jun 18; 60(6):567-77. PubMed ID: 15334157
    [Abstract] [Full Text] [Related]

  • 24. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM, Vega GL, Tomassini JE, Tershakovec AM.
    Am J Cardiol; 2009 Aug 15; 104(4):548-53. PubMed ID: 19660610
    [Abstract] [Full Text] [Related]

  • 25. Comparative effects of simvastatin and lovastatin in patients with hypercholesterolemia. The Simvastatin and Lovastatin Multicenter Study Participants.
    Farmer JA, Washington LC, Jones PH, Shapiro DR, Gotto AM, Mantell G.
    Clin Ther; 1992 Aug 15; 14(5):708-17. PubMed ID: 1468089
    [Abstract] [Full Text] [Related]

  • 26. [Comparison about the efficacy and tolerability between simvastatin and bezafibrate in the treatment of hypercholesterolemia].
    Bruckert E, Truffert J, De Gennes JL.
    Ann Med Interne (Paris); 1991 Aug 15; 142(7):505-10. PubMed ID: 1789528
    [Abstract] [Full Text] [Related]

  • 27. [Treatment of dyslipidemia of the elderly with simvastatin and pravastatin. Effectiveness and tolerance].
    Panuccio D, Trabatti MR, Romani A.
    Clin Ter; 1994 May 15; 144(5):419-24. PubMed ID: 7924180
    [Abstract] [Full Text] [Related]

  • 28. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
    O'Brien RC, Simons LA, Clifton P, Cooper ME, Jennings GL, Jerums G, Nestel PJ, Sullivan D.
    Med J Aust; 1990 May 07; 152(9):480-3. PubMed ID: 2199801
    [Abstract] [Full Text] [Related]

  • 29. [Simvastatin in the treatment of hypercholesterolemia].
    Cigala O, Pancallo MT, Della Valle M, Marasco A, Malarbi AL.
    Clin Ter; 1991 Jun 15; 137(5):333-7. PubMed ID: 1832606
    [Abstract] [Full Text] [Related]

  • 30. [The effects of the cholesterol synthesis inhibitor simvastatin in patients with hypercholesterolemia with and without diabetes mellitus].
    van Deursen RT, Nieuwenhuijzen Kruseman AC, Degenaar CP, Wolffenbuttel BH.
    Ned Tijdschr Geneeskd; 1990 Nov 03; 134(44):2142-6. PubMed ID: 2247172
    [Abstract] [Full Text] [Related]

  • 31. Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine.
    Vanhaecke J, Van Cleemput J, Van Lierde J, Daenen W, De Geest H.
    Transplantation; 1994 Jul 15; 58(1):42-5. PubMed ID: 8036706
    [Abstract] [Full Text] [Related]

  • 32. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].
    Riesen WF, Keller U, Del Bufalo A, Reutter FW, Baur HR, Golay A, Bertel O, Kummer H, Kistler H, Ammann F.
    Schweiz Med Wochenschr; 1989 Dec 02; 119(48):1719-23. PubMed ID: 2694363
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T, Davidson M, Shah A, Maccubbin D, Meehan A, Zakson M, Tribble D, Veltri E, Mitchel Y.
    Clin Ther; 2006 Jun 02; 28(6):849-59. PubMed ID: 16860168
    [Abstract] [Full Text] [Related]

  • 34. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.
    Park S, Kang HJ, Rim SJ, Ha JW, Oh BH, Chung N, Cho SY.
    Clin Ther; 2005 Jul 02; 27(7):1074-82. PubMed ID: 16154486
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study).
    Ballantyne CM, Davidson MH, McKenney J, Keller LH, Bajorunas DR, Karas RH.
    Am J Cardiol; 2008 May 15; 101(10):1428-36. PubMed ID: 18471454
    [Abstract] [Full Text] [Related]

  • 36. [Comparison of the effects of omega-3 polyunsaturated fatty acids and Olbetam (Acipimox) in the treatment of hypertriglyceridemia].
    Zák A, Zeman M, Vítková D.
    Cas Lek Cesk; 1994 Dec 22; 133(24):755-8. PubMed ID: 7834677
    [Abstract] [Full Text] [Related]

  • 37. [Effectiveness and tolerability of simvastatin in subjects with primary hypercholesterolemia. Multicenter study].
    Finardi G, Perani G, Tramarin R, Ricciardi R, Falaschi F, Franco C.
    Clin Ter; 1993 Mar 22; 142(3):225-33. PubMed ID: 8482062
    [Abstract] [Full Text] [Related]

  • 38. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep 22; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 39. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.
    Clin Ther; 2008 Jan 22; 30(1):84-97. PubMed ID: 18343245
    [Abstract] [Full Text] [Related]

  • 40. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS, Bacon SP, Illingworth DR.
    J Lab Clin Med; 2003 Apr 22; 141(4):250-6. PubMed ID: 12677170
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 18.